Intas Pharmaceuticals, Ltd. et al. v. Atossa Therapeutics, Inc.

PGR2025-00043

Court decision.

Jurisdiction
US PTAB
Case Number
PGR2025-00043
Judge(s)
Sheridan K. Snedden, Christopher C. Kennedy, Jamie T. Wizz
Decision Date
4 March 2025

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Intas Pharmaceuticals, Ltd. et al. vs Atossa Therapeutics, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-01335

Apple Inc.vsProxense, LLC

Apple has filed an IPR petition challenging Proxense’s ’905 patent on obviousness grounds, relying on Ludtke and Kon prior art and arguing that discretionary denial is unwarranted.

patentIPR2025-00250

Amazon.com, Inc. et al.vsNL Giken Inc.

Amazon has filed an IPR petition seeking cancellation of eight claims of NL Giken’s ’236 TV safety‑monitoring patent, alleging obviousness over several pre‑AIA references. The petition also argues that discretionary denial is unwarranted under the Fintiv framework.

patentIPR2024-01457

Kangxi Communication Technologies (Shanghai) Co., Ltd.vsSKYWORKS SOLUTIONS, INC.

Kangxi Communication Technologies has filed an IPR petition seeking to invalidate claims 1‑11 of Skyworks’ 9,148,194 RF switch patent, asserting obviousness over the Huang and Seshimo references. The petition also argues that discretionary denial is inappropriate.

patentIPR2024-01223

Samsung Display Co., Ltd. et al.vsPictiva Displays International Ltd. et al.

Samsung Display successfully challenged Pictiva Displays' patent claims in an IPR proceeding, demonstrating a reasonable likelihood of success on obviousness grounds. The Board found that combinations of prior art references were sufficient to invalidate several key display technology claims.

patentIPR2025-00751

USAA Federal Savings BankvsPACid Technologies, LLC

USAA and PACid Technologies have jointly moved to terminate IPR2025-00751 concerning patent 9,876,771 after resolving related district‑court litigation.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call